Rivas Medical Weight Loss

Rivas Medical Weight Loss operates a physician-supervised weight management practice in Nottingham, Maryland, with telehealth services extending to Virginia and Florida. The clinic specializes in GLP-1 receptor agonist therapy, offering both semaglutide and tirzepatide as primary pharmaceutical interventions for patients with obesity and metabolic dysfunction. Medical oversight ensures appropriate patient selection, dosing protocols, and monitoring for contraindications or adverse effects throughout treatment duration.

The clinic's weight loss programs center on two FDA-approved peptide medications: semaglutide, a GLP-1 agonist administered weekly via subcutaneous injection, and tirzepatide, a dual GIP/GLP-1 receptor agonist with enhanced efficacy in clinical trials. Both medications function by slowing gastric emptying, reducing appetite signaling in the hypothalamus, and improving insulin sensitivity. Rivas Medical Weight Loss incorporates body composition analysis to track fat mass versus lean tissue changes, distinguishing their approach from scale-weight-only monitoring. Nutritional counseling accompanies peptide therapy to address macronutrient distribution, meal timing, and dietary patterns that support medication efficacy and prevent muscle loss during caloric restriction.

The medical team at the Nottingham location provides initial consultations to evaluate patient candidacy for GLP-1 therapy, reviewing medical history for contraindications such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease. Providers assess baseline metabolic markers including hemoglobin A1c, fasting glucose, lipid panels, and thyroid function before initiating treatment. Follow-up protocols include regular check-ins to titrate medication dosing, monitor side effects such as nausea or gastrointestinal disturbances, and adjust nutritional plans based on patient response and weight loss trajectory.

Patients at Rivas Medical Weight Loss can expect structured onboarding that includes baseline body composition scanning, laboratory work, and education on self-administration of subcutaneous injections. The clinic provides specific guidance on injection technique, site rotation, and proper medication storage. Treatment timelines typically span several months, with dosage escalation occurring every four weeks based on tolerance and clinical response. The practice schedules regular accountability appointments to review progress, troubleshoot barriers to adherence, and modify treatment plans when weight loss plateaus occur or side effects require intervention.

With a 4.9-star rating across 175 Google reviews, the clinic has established patient satisfaction metrics reflecting consistent experiences with administrative staff, nursing support, and office operations in Nottingham. Telehealth availability for Maryland, Virginia, and Florida residents expands access beyond the Baltimore metropolitan area, allowing remote consultations for medication management and follow-up care. The practice accepts various payment structures for weight loss services, and the reception team coordinates insurance verification for medications where coverage applies, though many GLP-1 therapies for weight management require out-of-pocket payment when prescribed outside diabetes indications.